Gotowa bibliografia na temat „Kynurenine”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Kynurenine”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Kynurenine"
Maget, Alexander, Martina Platzer, Susanne A. Bengesser, Frederike T. Fellendorf, Armin Birner, Robert Queissner, Carlo Hamm i in. "Differences in Kynurenine Metabolism During Depressive, Manic, and Euthymic Phases of Bipolar Affective Disorder". Current Topics in Medicinal Chemistry 20, nr 15 (1.06.2020): 1344–52. http://dx.doi.org/10.2174/1568026619666190802145128.
Pełny tekst źródłaChen, Yiquan, i Gilles J. Guillemin. "Kynurenine Pathway Metabolites in Humans: Disease and Healthy States". International Journal of Tryptophan Research 2 (styczeń 2009): IJTR.S2097. http://dx.doi.org/10.4137/ijtr.s2097.
Pełny tekst źródłaBadawy, Abdulla A. B., i Samina Bano. "Tryptophan Metabolism in Rat Liver after Administration of Tryptophan, Kynurenine Metabolites, and Kynureninase Inhibitors". International Journal of Tryptophan Research 9 (styczeń 2016): IJTR.S38190. http://dx.doi.org/10.4137/ijtr.s38190.
Pełny tekst źródłaMajláth, Zsófia, i László Vécsei. "A kinureninrendszer és a stressz". Orvosi Hetilap 156, nr 35 (sierpień 2015): 1402–5. http://dx.doi.org/10.1556/650.2015.30246.
Pełny tekst źródłaHafstad Solvang, Stein-Erik, Jan Erik Nordrehaug, Dag Aarsland, Johannes Lange, Per Magne Ueland, Adrian McCann, Øivind Midttun, Grethe S. Tell i Lasse Melvaer Giil. "Kynurenines, Neuropsychiatric Symptoms, and Cognitive Prognosis in Patients with Mild Dementia". International Journal of Tryptophan Research 12 (styczeń 2019): 117864691987788. http://dx.doi.org/10.1177/1178646919877883.
Pełny tekst źródłaGawel, Kinga. "A Review on the Role and Function of Cinnabarinic Acid, a “Forgotten” Metabolite of the Kynurenine Pathway". Cells 13, nr 5 (5.03.2024): 453. http://dx.doi.org/10.3390/cells13050453.
Pełny tekst źródłaBüki, Alexandra, Gabriella Kekesi, Gyongyi Horvath i László Vécsei. "A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia". International Journal of Molecular Sciences 22, nr 18 (16.09.2021): 10016. http://dx.doi.org/10.3390/ijms221810016.
Pełny tekst źródłaSzűcs, Edina, Azzurra Stefanucci, Marilisa Pia Dimmito, Ferenc Zádor, Stefano Pieretti, Gokhan Zengin, László Vécsei, Sándor Benyhe, Marianna Nalli i Adriano Mollica. "Discovery of Kynurenines Containing Oligopeptides as Potent Opioid Receptor Agonists". Biomolecules 10, nr 2 (12.02.2020): 284. http://dx.doi.org/10.3390/biom10020284.
Pełny tekst źródłaMyint, A. M. "Role of Tryptophan-kynurenine Pathway in Depression: Psychopathological Aspect". European Psychiatry 24, S1 (styczeń 2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)70521-8.
Pełny tekst źródłaZakharov, Gennady A., Alexander V. Zhuravlev, Tatyana L. Payalina, Nikolay G. Kamyshev i Elena V. Savvateeva-Popova. "The influence of D. melanogaster mutations of the kynurenine pathway of tryptophan metabolism on locomotor behavior and expression of genes belonging to glutamatergic and cholinergic systems". Ecological genetics 9, nr 2 (15.06.2011): 65–73. http://dx.doi.org/10.17816/ecogen9265-73.
Pełny tekst źródłaRozprawy doktorskie na temat "Kynurenine"
Milne, Gavin D. S. "Inhibition studies of kynurenine 3-monooxygenase". Thesis, University of St Andrews, 2013. http://hdl.handle.net/10023/4101.
Pełny tekst źródłaThevandavakkam, Mathuravani Aaditiyaa. "Deciphering the kynurenine-3-monooxygenase interactome". Thesis, University of Leicester, 2011. http://hdl.handle.net/2381/10070.
Pełny tekst źródłaBell, Helen Barbara. "Characterisation of the active site of kynurenine 3-monooxygenase". Thesis, University of Edinburgh, 2016. http://hdl.handle.net/1842/20397.
Pełny tekst źródłaWilkinson, Martin. "Structural dynamics and ligand binding in kynurenine-3-monooxygenase". Thesis, University of Edinburgh, 2013. http://hdl.handle.net/1842/7965.
Pełny tekst źródłaOwe-Young, Robert School of Medicine UNSW. "Kynurenine pathway metabolism at the blood-brain barrier". Awarded by:University of New South Wales. School of Medicine, 2006. http://handle.unsw.edu.au/1959.4/26183.
Pełny tekst źródłaTaylor, Mark Robert Duncan. "High-resolution structural studies of kynurenine 3-monooxygenase". Thesis, University of Edinburgh, 2018. http://hdl.handle.net/1842/28913.
Pełny tekst źródłaSwaih, Aisha Mahmod O. "Functional and localization studies of human kynurenine 3-monooxygenase". Thesis, University of Leicester, 2016. http://hdl.handle.net/2381/37835.
Pełny tekst źródłaKolodziej, Lukasz. "An investigation of the kynurenine pathway in experimental arthritis". Thesis, Imperial College London, 2011. http://hdl.handle.net/10044/1/9641.
Pełny tekst źródłaSkouras, Christos. "Kynurenine metabolism and organ dysfunction in human acute pancreatitis". Thesis, University of Edinburgh, 2017. http://hdl.handle.net/1842/28898.
Pełny tekst źródłaUrenjak, Jutta A., i Tihomir P. Obrenovitch. "Accumulation of quinolinic acid with euro-inflammation: does it mean excitotoxicity?" Thesis, Kluwer Academic, Plenum Publishers, New York, 2003. http://hdl.handle.net/10454/2833.
Pełny tekst źródłaKsiążki na temat "Kynurenine"
Schwarcz, Robert, Simon N. Young i Raymond R. Brown, red. Kynurenine and Serotonin Pathways. Boston, MA: Springer New York, 1991. http://dx.doi.org/10.1007/978-1-4684-5952-4.
Pełny tekst źródłaMittal, Sandeep, red. Targeting the Broadly Pathogenic Kynurenine Pathway. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-11870-3.
Pełny tekst źródłaW, Stone T., red. Quinolinic acid and the kynurenines. Boca Raton, Fla: CRC Press, 1989.
Znajdź pełny tekst źródłaRobert, Schwarcz, Young Simon N i Brown Raymond R, red. Kynurenine and serotonin pathways: Progress in tryptophan research. New York: Plenum Press, 1991.
Znajdź pełny tekst źródłaRickards, Edward Hugh Galbraith. Plasma kynurenine tryptophan metabolites and associated substances in Gilles de la Tourette's Syndrome. Birmingham: University of Birmingham, 1999.
Znajdź pełny tekst źródłaLázló, Vécsei, red. Kynurenines in the brain: From experiments to clinics. Hauppauge, NY: Nova Science Publishers, 2005.
Znajdź pełny tekst źródłaMirza, Sarwarbeg. The hepatic and the peripheral metabolism of tryptophan via the kynurenine pathway in children with biliary atresiaand with orthotopic liver transplant: The assessment of the relationship between the levels of the kynurenine metabolites, neopterin, biopterin and liver function tests. [Guildford]: University of Surrey, 1995.
Znajdź pełny tekst źródłaNaleem, Wazeer A. A study of urinary kynurenine metabolites in pre-pubertal, pubertal and post-pubertal male offsprings of families with family history negative and family history positive of alcoholism. [Guildford]: University of Surrey, 1995.
Znajdź pełny tekst źródłaLapin, Izjaslav P. The neuroactivities of kynurenines: Stress, anxiety, depression, alcoholism, epilepsy : the 2000 Oswald Schmiedeberg lecture. Tartu: Tartu Ülikool, 2000.
Znajdź pełny tekst źródłaMittal, Sandeep. Targeting the Broadly Pathogenic Kynurenine Pathway. Springer, 2016.
Znajdź pełny tekst źródłaCzęści książek na temat "Kynurenine"
Schomburg, Dietmar, i Dörte Stephan. "Kynurenine 3-monooxygenase". W Enzyme Handbook, 433–36. Berlin, Heidelberg: Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-57942-4_91.
Pełny tekst źródłaSchomburg, Dietmar, i Dörte Stephan. "Kynurenine-oxoglutarate transaminase". W Enzyme Handbook 13, 235–38. Berlin, Heidelberg: Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-642-59176-1_46.
Pełny tekst źródłaSchomburg, Dietmar, i Dörte Stephan. "Kynurenine-glyoxylate transaminase". W Enzyme Handbook 13, 491–93. Berlin, Heidelberg: Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-642-59176-1_98.
Pełny tekst źródłaOkuno, E., i R. Kido. "Kynureninase and Kynurenine 3-Hydroxylase in Mammalian Tissues". W Advances in Experimental Medicine and Biology, 167–76. Boston, MA: Springer New York, 1991. http://dx.doi.org/10.1007/978-1-4684-5952-4_15.
Pełny tekst źródłaMinatogawa, Y., C. Kawai, S. Hatada i M. Sato. "Liver Specific Kynurenine (Alanine)". W Advances in Experimental Medicine and Biology, 471–76. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4613-0381-7_73.
Pełny tekst źródłaSchomburg, Dietmar, i Dörte Stephan. "Kynurenine 7, 8-hydroxylase". W Enzyme Handbook, 745–47. Berlin, Heidelberg: Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-57942-4_154.
Pełny tekst źródłaRudzite, V., i E. Jurika. "Kynurenine and Lipid Metabolism". W Advances in Experimental Medicine and Biology, 463–66. Boston, MA: Springer New York, 1991. http://dx.doi.org/10.1007/978-1-4684-5952-4_45.
Pełny tekst źródłaMajláth, Zsófia, Levente Szalárdy, Dénes Zádori, Péter Klivényi, Ferenc Fülöp, József Toldi i László Vécsei. "Neuroprotection by Kynurenine Metabolites". W Handbook of Neurotoxicity, 1403–16. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-5836-4_165.
Pełny tekst źródłaMajláth, Zsófia, Levente Szalárdy, Dénes Zádori, Péter Klivényi, Ferenc Fülöp, József Toldi i László Vécsei. "Neuroprotection by Kynurenine Metabolites". W Handbook of Neurotoxicity, 1067–80. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-15080-7_165.
Pełny tekst źródłaWeil-Fugazza, J. "Endogenous Kynurenine Derivatives and Pain". W Advances in Experimental Medicine and Biology, 83–87. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4613-0381-7_11.
Pełny tekst źródłaStreszczenia konferencji na temat "Kynurenine"
Gosker, Harry R., Gerard Clarke, John F. Cryan i Annemie M. Schols. "Impaired skeletal muscle kynurenine metabolism in patients with COPD". W ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa940.
Pełny tekst źródłaTharawadeephimuk, Waranan, Chaiyavat Chaiyasut, Sasithorn Sirilun i Phakkharawat Sittiprapaporn. "Preliminary Study of Probiotics and Kynurenine Pathway in Autism Spectrum Disorder". W 2019 16th International Conference on Electrical Engineering/Electronics, Computer, Telecommunications and Information Technology (ECTI-CON). IEEE, 2019. http://dx.doi.org/10.1109/ecti-con47248.2019.8955380.
Pełny tekst źródłaTriplett, Todd A., Kendra Triplett, Everett Stone, Michelle Zhang, Mark Manfredi, Candice Lamb, Yuri Tanno, Lauren Ehrlich i George Georgiou. "Abstract 5571: Immune-checkpoint inhibition via enzyme-mediated degradation of kynurenine". W Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-5571.
Pełny tekst źródłaPinto, Sheena, Christoph Steeneck, Michael Albers, Simon Anderhub, Manfred Birkel, Larisa Buselic-Wölfel, Gisela Eisenhardt, Claus Kremoser, Thomas Hoffmann i Ulrich Deuschle. "Abstract 1210: Targeting the IDO1-Kynurenine-AhR pathway for cancer immunotherapy". W Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-1210.
Pełny tekst źródłaPinto, Sheena, Christoph Steeneck, Michael Albers, Simon Anderhub, Manfred Birkel, Larisa Buselic-Wölfel, Gisela Eisenhardt, Claus Kremoser, Thomas Hoffmann i Ulrich Deuschle. "Abstract 1210: Targeting the IDO1-Kynurenine-AhR pathway for cancer immunotherapy". W Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-1210.
Pełny tekst źródłaBotticelli, Andrea, Bruna Cerbelli, Luana Lionetto, Ilaria Zizzari, Annalina Pisano, Michela Roberto, Elisa Onesti i in. "Abstract 5705: The key role of kynurenine in anti-PD-1 failure". W Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-5705.
Pełny tekst źródłaBreda, Carlo, Aisha M. Swaih, Mariaelena Repici i Flaviano Giorgini. "A29 Kynurenine 3-monooxygenase interacts with huntingtin at the outer mitochondrial membrane". W EHDN 2018 Plenary Meeting, Vienna, Austria, Programme and Abstracts. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/jnnp-2018-ehdn.27.
Pełny tekst źródłaPoulain-Godefroy, Odile, Mélina Le Roux, Gwenola Kervoaze, Anais Ollivier, Muriel Pichavant i Philippe Gosset. "Kynurenine pathway as a modulator of inflammation in COPD and its exacerbations." W ERS Lung Science Conference 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/23120541.lsc-2022.61.
Pełny tekst źródłaWangpaichitr, Medhi, Chunjing Wu, Dan JM Nguyen, Ying-Ying Li, Lynn G. Feun i Niramol Savaraj. "Abstract 5478: Targeting kynurenine pathway for the treatment of cisplatin-resistant lung cancer". W Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-5478.
Pełny tekst źródłaBessede, Alban, Antoine Italiano, Assia Chaïbi, Christophe Rey, Imane Nafia, Sylvestre le Moulec, Sophie Cousin, Maud Toulmonde, Céline Auzanneau i Marina Pulido. "Abstract 5716: Functional evidence for an immunosuppressive role of kynurenine in cancer patients". W Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-5716.
Pełny tekst źródła